• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Authors' reply.新型冠状病毒肺炎与ROX指数：是时候为非重症监护病房收治的患者设定新阈值了。作者回复
Pulmonology. 2021 Sep-Oct;27(5):475-476. doi: 10.1016/j.pulmoe.2021.07.001. Epub 2021 Jul 30.
2
COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.COVID-19 肺炎与 ROX 指数：为 ICU 外收治患者设定新阈值的时机。
Pulmonology. 2022 Jan-Feb;28(1):13-17. doi: 10.1016/j.pulmoe.2021.04.003. Epub 2021 May 7.
3
COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Author's reply.新型冠状病毒肺炎与ROX指数：是时候为非重症监护病房收治患者设定新阈值了。作者回复
Pulmonology. 2022 Jul-Aug;28(4):322-323. doi: 10.1016/j.pulmoe.2022.02.010. Epub 2022 Mar 4.
4
[Value of modified ROX index in predicting the outcome of patients with acute respiratory distress syndrome due to SARS-CoV-2 infection treated with high-flow nasal cannula oxygen therapy].[改良ROX指数对预测新型冠状病毒2型感染所致急性呼吸窘迫综合征患者接受高流量鼻导管吸氧治疗预后的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jun;36(6):585-590. doi: 10.3760/cma.j.cn121430-20240228-00171.
5
Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study.呼吸模式、辅助呼吸肌做功和气体交换评估对 ICU 外呼吸衰竭恶化后中重度 COVID-19 相关 ARDS 患者行 NIV 治疗失败的预测作用：COVID-NIV 观察性研究。
BMC Anesthesiol. 2022 Oct 1;22(1):307. doi: 10.1186/s12871-022-01847-7.
6
Early Variation of Respiratory Indexes to Predict Death or ICU Admission in Severe Acute Respiratory Syndrome Coronavirus-2-Related Respiratory Failure.早期呼吸指数变化对预测严重急性呼吸综合征冠状病毒 2 相关呼吸衰竭患者死亡或入住 ICU 的价值。
Respiration. 2022;101(7):632-637. doi: 10.1159/000522275. Epub 2022 Mar 15.
7
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.ROX 指数可预测因 SARS-CoV-2 导致的急性呼吸衰竭行高流量鼻导管治疗的成功率。
Respir Med. 2021 Nov-Dec;189:106638. doi: 10.1016/j.rmed.2021.106638. Epub 2021 Oct 6.
8
Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.伴有 COVID-19 肺炎、甲型或乙型流感肺炎与无病毒性肺炎的 ICU 住院患者的早期和晚期血流感染与呼吸道感染合并感染发生率的比较：威尔士多中心 ICU 队列研究。
Crit Care. 2022 Jun 2;26(1):158. doi: 10.1186/s13054-022-04026-9.
9
Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.改善重症监护病房中新冠肺炎患者或相关病症患者预后的综合照护措施——一项快速综述
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD013819. doi: 10.1002/14651858.CD013819.
10
[ROX index, high-flow oxygen therapy and COVID-19 pneumonia].[罗克斯指数、高流量氧疗与新型冠状病毒肺炎]
Medicina (B Aires). 2023;83(3):411-419.

引用本文的文献

1
Predictive Factors of Oxygen Therapy Failure in Patients with COVID-19 in the Emergency Department.急诊科新冠肺炎患者氧疗失败的预测因素
Open Access Emerg Med. 2023 Oct 4;15:355-365. doi: 10.2147/OAEM.S430600. eCollection 2023.
2
Research on SARS-COV-2 pandemic: a narrative review focused on the Italian contribution.2019冠状病毒病大流行研究：一项聚焦意大利贡献的叙述性综述
J Anesth Analg Crit Care. 2021 Nov 17;1(1):14. doi: 10.1186/s44158-021-00017-4.
3
Lessons from COVID-19 in the management of acute respiratory failure.2019冠状病毒病在急性呼吸衰竭管理方面的经验教训。
Breathe (Sheff). 2023 Mar;19(1):230035. doi: 10.1183/20734735.0035-2023. Epub 2023 May 23.
4
Ratio of Oxygen Saturation to Inspired Oxygen, ROX Index, Modified ROX Index to Predict High Flow Cannula Success in COVID-19 Patients: Multicenter Validation Study.氧饱和度与吸入氧比值、ROX 指数、改良 ROX 指数预测 COVID-19 患者高流量鼻导管通气成功的多中心验证研究。
West J Emerg Med. 2023 Apr 28;24(3):511-521. doi: 10.5811/westjem.58311.
5
Noninvasive Respiratory Assist Devices in the Management of COVID-19-related Hypoxic Respiratory Failure: Pune ISCCM COVID-19 ARDS Study Consortium (PICASo).非侵入性呼吸辅助设备在新型冠状病毒肺炎相关低氧性呼吸衰竭管理中的应用：浦那国际重症监护与危重病医学学会新型冠状病毒肺炎急性呼吸窘迫综合征研究联盟（PICASo）
Indian J Crit Care Med. 2022 Jul;26(7):791-797. doi: 10.5005/jp-journals-10071-24241.
6
The Relationship of Respiratory Rate-Oxygenation (ROX) and Modified ROX Index With High-Flow Nasal Cannula Oxygen Therapy in COVID-19 Patients: An Observational Pilot Study.呼吸频率-氧合（ROX）及改良ROX指数与新型冠状病毒肺炎患者高流量鼻导管氧疗的关系：一项观察性初步研究
Cureus. 2022 Dec 24;14(12):e32900. doi: 10.7759/cureus.32900. eCollection 2022 Dec.
7
Comparison of ROX index (SpO/FIO ratio/respiratory rate) with a modified dynamic index incorporating PaO/FIO ratio and heart rate to predict high flow nasal cannula outcomes among patients with acute respiratory failure: a single centre retrospective study.比较 ROX 指数（SpO/FIO 比值/呼吸频率）与改良的动态指数（包括 PaO/FIO 比值和心率），以预测急性呼吸衰竭患者使用高流量鼻导管的结局：一项单中心回顾性研究。
BMC Pulm Med. 2022 Sep 16;22(1):350. doi: 10.1186/s12890-022-02121-9.
8
Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome.脉搏血氧饱和度测定在急性呼吸窘迫综合征诊断和治疗中的应用。
Lancet Respir Med. 2022 Nov;10(11):1086-1098. doi: 10.1016/S2213-2600(22)00058-3. Epub 2022 Aug 29.
9
Silent hypoxia is not an identifiable characteristic in patients with COVID-19 infection.静默低血氧症并不是 COVID-19 感染患者的一个可识别特征。
Respir Med. 2022 Jun;197:106858. doi: 10.1016/j.rmed.2022.106858. Epub 2022 Apr 26.
10
Early Variation of Respiratory Indexes to Predict Death or ICU Admission in Severe Acute Respiratory Syndrome Coronavirus-2-Related Respiratory Failure.早期呼吸指数变化对预测严重急性呼吸综合征冠状病毒 2 相关呼吸衰竭患者死亡或入住 ICU 的价值。
Respiration. 2022;101(7):632-637. doi: 10.1159/000522275. Epub 2022 Mar 15.

本文引用的文献

1
ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?对接受高流量吸氧治疗的重症新冠肺炎患者进行ROX监测：与呼吸频率相比是否具有真正的附加价值？
Pulmonology. 2021 Sep-Oct;27(5):474. doi: 10.1016/j.pulmoe.2021.06.011. Epub 2021 Jul 9.
2
Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.将 PaO2 标准化为 P/F 比值以预测 COVID-19 导致的急性呼吸衰竭患者的院内死亡率：一项前瞻性试点研究。
Eur J Intern Med. 2021 Oct;92:48-54. doi: 10.1016/j.ejim.2021.06.002. Epub 2021 Jun 17.
3
The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study.资源受限环境下高流量鼻导管吸氧对重症新型冠状病毒肺炎的作用：一项多中心前瞻性观察性研究。
EClinicalMedicine. 2020 Nov;28:100570. doi: 10.1016/j.eclinm.2020.100570. Epub 2020 Oct 6.
4
High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU.高流量鼻氧疗：一种安全、有效的 COVID-19 非 ICU 患者治疗方法。
Eur Respir J. 2020 Nov 12;56(5). doi: 10.1183/13993003.01154-2020. Print 2020 Nov.
5
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.回顾性分析高流量鼻导管通气在 COVID-19 相关中重度低氧血症性呼吸衰竭中的应用。
BMJ Open Respir Res. 2020 Aug;7(1). doi: 10.1136/bmjresp-2020-000650.
6
Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate.监测高流量鼻导管治疗新型冠状病毒肺炎重症患者：少即是多，更应关注呼吸频率。
Intensive Care Med. 2020 Nov;46(11):2094-2095. doi: 10.1007/s00134-020-06199-9. Epub 2020 Jul 31.

COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Authors' reply.

作者信息

Vega M L, Dongilli R, Olaizola G, Colaianni N, Sayat M C, Pisani L, Romagnoli M, Spoladore G, Prediletto I, Montiel G, Nava S

机构信息

Non-Invasive Respiratory Support Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires. Argentina; IRCCS Azienda Ospedaliera-Universitaria, Division of Respiratory and Critical Care SantOrsola Hospital, Bologna Italia.

Division of Respiratory Diseases with intermediate respiratory intensive care units, Central Hospital of Bolzano, Bolzano, Italy.

出版信息

Pulmonology. 2021 Sep-Oct;27(5):475-476. doi: 10.1016/j.pulmoe.2021.07.001. Epub 2021 Jul 30.

DOI:10.1016/j.pulmoe.2021.07.001
PMID:34334332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8321775/
Abstract
摘要